Condition
UTI - Lower Urinary Tract Infection
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (1)
P 4 (2)
Trial Status
Completed2
Withdrawn1
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07189429Not ApplicableCompleted
Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting
NCT06940622Not ApplicableRecruiting
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
NCT04496726Phase 2Terminated
Cranberry and Quillaja on Symptoms of Uncomplicated UTI
NCT03996057Phase 4Withdrawn
Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention
NCT03366207Phase 4CompletedPrimary
Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
Showing all 5 trials